StockData

Alto Ingredients vs Aemetis

ALTO and AMTX side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALTO and AMTX compare

Alto Ingredients is the larger company, worth 3.4 times as much as Aemetis ($285M against $85.2M).

Alto Ingredients grew revenue faster over the last twelve months (1.1% versus −1.7% for Aemetis).

Alto Ingredients keeps more of each dollar of sales as profit, with a net margin of 5.5% compared with −27.4% at Aemetis.

Alto Ingredients scores higher on the StockData Score (13 against 4 for Aemetis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALTOAMTX
Size and price
Market cap$285M$85.2M
Share price$3.68$1.18
Change, 1 year89.7%−39.5%
Change, 5 years−27.1%−93.3%
Beta (5Y)−1.13−2.72
Employees390220
StockData Score
Total score13 (better)4
Valuation score4 (better)1
Growth score22
Performance score3 (better)1
Health score4 (better)0
Dividend score00
Valuation
P/E5.6×–
P/S0.3× (better)0.4×
P/B1.1×–
EV/EBITDA5.3×–
P/FCF5.7×–
FCF yield17.5% (better)−46.2%
Fair value$14.01–
Margin of safety73.7%–
Growth
Revenue growth (TTM)1.1% (better)−1.7%
Revenue growth, 5Y average0.46%3.6% (better)
Profitability
Gross margin6.8%10.9% (better)
Operating margin3.8% (better)−5.3%
Net margin5.5% (better)−27.4%
FCF margin5.3% (better)−17.9%
Return on equity22.2%–
Return on invested capital9.5% (better)−12.5%
Financial health
Debt / equity0.23–
Net debt / EBITDA0.60–
Interest coverage3.8× (better)−0.2×
Current ratio3.19 (better)0.08
Altman Z-score1.44 (better)−4.12
Piotroski F-score7 (better)4
Dividends and buybacks
Buyback yield–−28.0%
Shareholder yield0.00% (better)−28.0%
Ownership
Held by institutions46.3%24.5%
Held by insiders9.2%10.9%
Insider net buying, 12 months$361K (better)−$20.5K
Short interest, % of float7.0%13.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.